Active-ingredient Dossier
Lidocaine Hydrochloride Monohydrate
Active-ingredient Dossier for Lidocaine Hydrochloride Monohydrate (local anaesthetic). Australian brands, products, PBS listings, PBAC outcomes —…
- Brand: LACERAINE
- Brand: LIDOCAINE NORIDEM
- Brand: LIDOCAINE-BAXTER
- Brand: BETASOOTHE+
- Brand: BURN
- Brand: CO-PHENYLCAINE
- Therapeutic area: Pain Management
- Therapeutic area: Dermatology
- Therapeutic area: Cardiology
What is
Lidocaine Hydrochloride Monohydrate Lidocaine Hydrochloride Monohydrate is a local anaesthetic.
Therapeutic areas
Lidocaine Hydrochloride Monohydrate is registered across seven therapeutic areas. Pain Management has the largest share with seven brands, followed by Dermatology with three brands and Gastroenterology with three brands. Single-brand registrations exist in Pain & Anaesthesia, Neurology, Cardiology, and Infectious Disease.
Sponsor landscape
Fourteen sponsors market lidocaine hydrochloride monohydrate in Australia, including Orion Laboratories Pty Ltd trading as Evaris Pharma, Interpharma, Nova Pharmaceuticals, Aspen Pharmacare, Baxter Healthcare, and Concept Health Pharma.